한글목차

세계 지혈제 시장은 외과 수술 증가와 기술 발전에 힘입어 괄목할만한 성장을 보일 것으로 예상됩니다.

세계의 지혈제( 시장을 조사했으며, 시장 배경과 개요, 시장 성장에 영향을 미치는 각종 영향요인 분석, 규제 환경, R&D 및 특허 동향, 시장 규모 추이 및 예측, 지역별/주요 국가별 상세 분석, 주요 기업 분석 등의 정보를 정리하여 전해드립니다.

목차

주요 요약

범위와 정의

제1장 시장

• 동향 : 현재 및 향후 영향 평가
• 공급망 개요
  • 밸류체인 분석
  • 시장 맵
  • 원재료 및 부품 가격 예측
• R&D 리뷰
  • 특허 출원 동향(국가/기업별)
• 규제 상황
• 주요 세계 이벤트의 영향 분석 : COVID-19
• 시장 역학 개요
  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회

제2장 용도

• 용도 분류
• 용도 개요
• 세계의 지혈제 시장(용도별)
  • 심장혈관 외과
  • 일반 외과
  • 부인과 외과
  • 정형외과
  • 신경외과
  • 기타
• 세계의 지혈제 시장(최종사용자별)
  • 병원
  • 외래수술센터(ASC)
  • 클리닉 및 의사 오피스
  • 기타

제3장 제품

• 제품 분류
• 제품 개요
• 세계의 지혈제 시장(유형별)
  • 시장 개요
• 세계의 지혈제 시장(유형별)
  • 산화 재생 셀룰로오스 기반
  • 트롬빈 기반
  • 콤비네이션
  • 젤라틴 기반
  • 콜라겐 기반
  • 기타
• 세계의 지혈제 시장(제제별)
  • 매트릭스 및 겔
  • 시트 및 패드
  • 스펀지
  • 분말

제4장 지역

• 지역 개요
• 성장 촉진요인 및 억제요인
• 북미
• 유럽
• 아시아태평양
• 라틴아메리카
• 기타 지역

제5장 시장 : 경쟁 벤치마킹 및 기업 개요

• 다음 프론티어
• 지역적 평가
  • Pfizer Inc. plc
  • Baxter International
  • B. Braun Holding GmbH & Co. KG
  • Teleflex Incorporated
  • Medtronic
  • Stryker Corporation
  • Boston Scientific Corporation
  • Samyang Holdings Corporation
  • Advanced Medical Solutions Group plc
  • Integra Life Sciences
  • Hemostasis, LLC.
  • Johnson and Johnson
  • Altaylar Medical
  • Anika Therapeutics, Inc.
  • Cryolife, Inc.

제6장 조사 방법

영문목차

“Global Hemostats Market Poised for Remarkable Growth, Driven by Rising Surgical Procedures and Technological Advancements.”

The hemostats market report provides a comprehensive analysis of the global market for hemostats products. The report contains crucial statistics concerning the status of prominent players in the hemostats market, highlighting key trends and potential opportunities within the market.

The report provides an analysis of the driving and restraining factors affecting market growth. This includes factors like technological advancements, and regulatory policies impacting the hemostats market. This report presents an extensive overview of the industry, encompassing both qualitative and quantitative data.

Furthermore, the report scrutinizes factors impacting the hemostats market from both the demand and supply sides. The report includes the detailed profiles of key players in the hemostats market. This section includes information on company profiles, product portfolios, market strategies, mergers and acquisitions, and their position in the market. The overall aim of this report is to provide stakeholders, businesses, investors, and researchers with a comprehensive understanding of hemostats market.

Market Segmentation:

Segmentation 1: by Application

• Cardiovascular Surgery
• General Surgery
• Gynecological Surgery
• Orthopedic Surgery
• Neurological Surgery
• Others

Segmentation 2: by End User

• Hospitals
• Ambulatory Surgical Centres
• Clinics and Physicans' Offices
• Others

Segmentation 3: by Type

• Oxidized Regenerated Cellulose-Based Hemostats
• Thrombin Based Hemostats
• Combination Hemostats
• Gelatin-Based Hemostats
• Collagen-Based Hemostats
• Others

Segmentation 4: by Formulation

• Matrix and Gel Hemostats
• Sheet and Pad Hemostats
• Sponge Hemostats
• Powder Hemostats

Segmentation 5: by Region

• North America
• Europe
• Asia-Pacific
• Rest-of-the-World

Key Questions Answered in this Report:

• What are the focus areas of the global hemostats market in the upcoming years?
• What is the value of revenue generated from hemostats market across the globe and at what rate is the demand expected to grow during the forecast period?
• Which product(s) is poised to be the primary revenue generator in the global hemostats market?
• Among hemostats segments, which is projected to capture the largest market share?
• In terms of applications, which segment is forecasted to experience the highest Compound Annual Growth Rate (CAGR) during the forecast period?
• Which end-user segment accounted for the largest share of the hemostats market?
• What are the key growth factors of this market? What are the major opportunities for existing market players and new entrants in the global hemostats market?
• What are the major challenges faced by the existing players in the market?
• Who are the major players dominating in the global hemostats market space?
• Which regions/countries are expected to offer significant growth opportunities for the vendors operating in the hemostats market for the forecast period?

Table of Contents

Executive Summary

Scope and Definition

1. Markets

• 1.1. Trends: Current and Future Impact Assessment
  • 1.1.1. Sample Text
  • 1.1.2. Trend 1
  • 1.1.3. Trend 2
  • 1.1.4. Trend 3
• 1.2. Supply Chain Overview
  • 1.2.1. Value Chain Analysis
  • 1.2.2. Market Map
  • 1.2.3. Pricing Forecast for Raw Materials and Components
• 1.3. Research and Development Review
  • 1.3.1. Patent Filing Trend (by Country, Company)
• 1.4. Regulatory Landscape
• 1.5. Impact Analysis for Key Global Events- Covid-19
• 1.6. Market Dynamics Overview
  • 1.6.1. Market Drivers
  • 1.6.2. Market Restraints
  • 1.6.3. Market Opportunities

2. Application

• 2.1. Application Segmentation
• 2.2. Application Summary
• 2.1. Global Hemostats Market (by Application)
  • 2.1.1. Cardiovascular Surgery
  • 2.1.2. General Surgery
  • 2.1.3. Gynecological Surgery
  • 2.1.4. Orthopedic Surgery
  • 2.1.5. Neurological Surgery
  • 2.1.6. Others
• 2.2. Global Hemostats Market (by End User)
  • 2.2.1. Hospitals
  • 2.2.2. Ambulatory Surgical Centres
  • 2.2.3. Clinics and Physicans' Offices
  • 2.2.4. Others

3. Products

• 3.1. Product Segmentation
• 3.2. Product Summary
• 3.3. Global Hemostats Market by Type
  • 3.3.1. Market Overview
    • 3.3.1.1. Analyst View
• 3.1. Global Hemostats Market (by Type)
  • 3.1.1. Oxidized Regenerated Cellulose-Based Hemostats
  • 3.1.2. Thrombin Based Hemostats
  • 3.1.3. Combination Hemostats
  • 3.1.4. Gelatin-Based Hemostats
  • 3.1.5. Collagen-Based Hemostats
  • 3.1.6. Others
• 3.2. Global Hemostats Market (by Formulation)
  • 3.2.1. Matrix and Gel Hemostats
  • 3.2.2. Sheet and Pad Hemostats
  • 3.2.3. Sponge Hemostats
  • 3.2.4. Powder Hemostats

4. Regions

• 4.1. Regional Summary
• 4.2. Drivers and Restraints
• 4.3. North America
  • 4.3.1. Regional Overview
  • 4.3.2. Driving Factors for Market Growth
  • 4.3.3. Factors Challenging the Market
  • 4.3.4. Application
  • 4.3.5. Product
  • 4.3.6. U.S.
  • 4.3.7. U.S. Hemostats Market by Application
  • 4.3.8. Canada
  • 4.3.9. Canada Hemostats Market by Application
• 4.4. Europe
  • 4.4.1. Regional Overview
  • 4.4.2. Driving Factors for Market Growth
  • 4.4.3. Factors Challenging the Market
  • 4.4.4. Application
  • 4.4.5. Product
  • 4.4.6. France
  • 4.4.7. France Hemostats Market by Application
  • 4.4.8. Germany
  • 4.4.9. Germany Hemostats Market by Application
  • 4.4.10. U.K.
  • 4.4.11. U.K. Hemostats Market by Application
  • 4.4.12. Italy
  • 4.4.13. Italy Hemostats Market by Application
  • 4.4.14. Spain
  • 4.4.15. Spain Hemostats Market by Application
  • 4.4.16. Rest of Europe
  • 4.4.17. Rest of Europe Hemostats Market by Application
• 4.5. Asia Pacific
  • 4.5.1. Regional Overview
  • 4.5.2. Driving Factors for Market Growth
  • 4.5.3. Factors Challenging the Market
  • 4.5.1. Application
  • 4.5.2. Product
  • 4.5.3. China
  • 4.5.4. China Hemostats Market by Application
  • 4.5.5. India
  • 4.5.6. India Hemostats Market by Application
  • 4.5.7. Japan
  • 4.5.8. Japan Hemostats Market by Application
  • 4.5.9. Australia
  • 4.5.10. Australia Hemostats Market by Application
  • 4.5.11. Rest-of-Asia Pacific
  • 4.5.12. Rest-of-Asia Pacific Hemostats Market by Application
• 4.6. Latin America
  • 4.6.1. Regional Overview
  • 4.6.2. Driving Factors for Market Growth
  • 4.6.3. Factors Challenging the Market
  • 4.6.4. Application
  • 4.6.5. Product
  • 4.6.6. Argentina
  • 4.6.7. Argentina Hemostats Market by Application
  • 4.6.8. Brazil
  • 4.6.9. Brazil Hemostats Market by Application
  • 4.6.10. Mexico
  • 4.6.11. Application
  • 4.6.12. Mexico Hemostats Market by Application
  • 4.6.13. Rest-of-Latin America
  • 4.6.14. Rest-of-Latin America Hemostats Market by Application
• 4.7. Rest-of-the-World
  • 4.7.1. Regional Overview
  • 4.7.2. Driving Factors for Market Growth
  • 4.7.3. Factors Challenging the Market
  • 4.7.4. Application
  • 4.7.5. Product

5. Markets - Competitive Benchmarking & Company Profiles

• 5.1. Next Frontiers…..
• 5.2. Geographic Assessment
  • 5.2.1. Pfizer Inc. plc
    • 5.2.1.1. Overview
    • 5.2.1.2. Top Products / Product Portfolio
    • 5.2.1.3. Top Competitors
    • 5.2.1.4. Target Customers
    • 5.2.1.5. Key Personnel
    • 5.2.1.6. Analyst View
    • 5.2.1.7. Market Share
  • 5.2.2. Baxter International
    • 5.2.2.1. Overview
    • 5.2.2.2. Top Products / Product Portfolio
    • 5.2.2.3. Top Competitors
    • 5.2.2.4. Target Customers
    • 5.2.2.5. Key Personnel
    • 5.2.2.6. Analyst View
    • 5.2.2.7. Market Share
  • 5.2.3. B. Braun Holding GmbH & Co. KG
    • 5.2.3.1. Overview
    • 5.2.3.2. Top Products / Product Portfolio
    • 5.2.3.3. Top Competitors
    • 5.2.3.4. Target Customers
    • 5.2.3.5. Key Personnel
    • 5.2.3.6. Analyst View
    • 5.2.3.7. Market Share
  • 5.2.4. Teleflex Incorporated
    • 5.2.4.1. Overview
    • 5.2.4.2. Top Products / Product Portfolio
    • 5.2.4.3. Top Competitors
    • 5.2.4.4. Target Customers
    • 5.2.4.5. Key Personnel
    • 5.2.4.6. Analyst View
    • 5.2.4.7. Market Share
  • 5.2.5. Medtronic
    • 5.2.5.1. Overview
    • 5.2.5.2. Top Products / Product Portfolio
    • 5.2.5.3. Top Competitors
    • 5.2.5.4. Target Customers
    • 5.2.5.5. Key Personnel
    • 5.2.5.6. Analyst View
    • 5.2.5.7. Market Share
  • 5.2.6. Stryker Corporation
    • 5.2.6.1. Overview
    • 5.2.6.2. Top Products / Product Portfolio
    • 5.2.6.3. Top Competitors
    • 5.2.6.4. Target Customers
    • 5.2.6.5. Key Personnel
    • 5.2.6.6. Analyst View
    • 5.2.6.7. Market Share
  • 5.2.7. Boston Scientific Corporation
    • 5.2.7.1. Overview
    • 5.2.7.2. Top Products / Product Portfolio
    • 5.2.7.3. Top Competitors
    • 5.2.7.4. Target Customers
    • 5.2.7.5. Key Personnel
    • 5.2.7.6. Analyst View
    • 5.2.7.7. Market Share
  • 5.2.8. Samyang Holdings Corporation
    • 5.2.8.1. Overview
    • 5.2.8.2. Top Products / Product Portfolio
    • 5.2.8.3. Top Competitors
    • 5.2.8.4. Target Customers
    • 5.2.8.5. Key Personnel
    • 5.2.8.6. Analyst View
    • 5.2.8.7. Market Share
  • 5.2.9. Advanced Medical Solutions Group plc
    • 5.2.9.1. Overview
    • 5.2.9.2. Top Products / Product Portfolio
    • 5.2.9.3. Top Competitors
    • 5.2.9.4. Target Customers
    • 5.2.9.5. Key Personnel
    • 5.2.9.6. Analyst View
    • 5.2.9.7. Market Share
  • 5.2.10. Integra Life Sciences
    • 5.2.10.1. Overview
    • 5.2.10.2. Top Products / Product Portfolio
    • 5.2.10.3. Top Competitors
    • 5.2.10.4. Target Customers
    • 5.2.10.5. Key Personnel
    • 5.2.10.6. Analyst View
    • 5.2.10.7. Market Share
  • 5.2.11. Hemostasis, LLC.
    • 5.2.11.1. Overview
    • 5.2.11.2. Top Products / Product Portfolio
    • 5.2.11.3. Top Competitors
    • 5.2.11.4. Target Customers
    • 5.2.11.5. Key Personnel
    • 5.2.11.6. Analyst View
    • 5.2.11.7. Market Share
  • 5.2.12. Johnson and Johnson
    • 5.2.12.1. Overview
    • 5.2.12.2. Top Products / Product Portfolio
    • 5.2.12.3. Top Competitors
    • 5.2.12.4. Target Customers
    • 5.2.12.5. Key Personnel
    • 5.2.12.6. Analyst View
    • 5.2.12.7. Market Share
  • 5.2.13. Altaylar Medical
    • 5.2.13.1. Overview
    • 5.2.13.2. Top Products / Product Portfolio
    • 5.2.13.3. Top Competitors
    • 5.2.13.4. Target Customers
    • 5.2.13.5. Key Personnel
    • 5.2.13.6. Analyst View
    • 5.2.13.7. Market Share
  • 5.2.14. Anika Therapeutics, Inc.
    • 5.2.14.1. Overview
    • 5.2.14.2. Top Products / Product Portfolio
    • 5.2.14.3. Top Competitors
    • 5.2.14.4. Target Customers
    • 5.2.14.5. Key Personnel
    • 5.2.14.6. Analyst View
    • 5.2.14.7. Market Share
  • 5.2.15. Cryolife, Inc.
    • 5.2.15.1. Overview
    • 5.2.15.2. Top Products / Product Portfolio
    • 5.2.15.3. Top Competitors
    • 5.2.15.4. Target Customers
    • 5.2.15.5. Key Personnel
    • 5.2.15.6. Analyst View
    • 5.2.15.7. Market Share

6. Research Methodology

• 6.1. Data Sources
  • 6.1.1. Primary Data Sources
  • 6.1.2. Secondary Data Sources
  • 6.1.3. Data Triangulation
• 6.2. Market Estimation and Forecast